# Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis

> **NCT00255567** · PHASE3 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 1142 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Sodium Stibogluconate
- **DRUG:** Paromomycin sulphate
- **DRUG:** SSG and Paromomycin sulphate

## Key facts

- **NCT ID:** NCT00255567
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 1142 (ACTUAL)
- **Last updated:** 2016-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255567, "Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00255567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*